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Upstate Medical UniVersity, 750 East Adams Street, Syracuse, New York 13210
ReceiVed August 10, 2009

We report different mesoporosity-dependent and functional group-dependent cytotoxicity and endocytosis
of various silica nanomaterials on suspended and adherent cells. This dependency further varied with
incubation time and particle dosage, and appeared to be associated with the particles’ endocytotic efficiency
and their chemical and physical properties. We studied two common mesoporous nanomaterials (MSNs),
MCM-41 and SBA-15, and one type of solid-cored silica microsphere, paralleled by their quaternary
amine functionalized counterparts. Compared to SBA-15, MCM-41 has a larger surface area but smaller
pore size, whereas SMS exhibits low surface area and poor porosity. In Jurkat cells, SBA-15 and MCM41 exhibited different cytotoxicity profiles. However, no significant cell death was detected when treated
with the aminated MSNs, indicating that the positively charged quaternary amines prevented cellular
injury from mesoporous nanoparticles. Furthermore, the effective internalization of MSN but not aminatedMSNs was clearly observed, in line with their consequent cytotoxicity. SK-N-SH (human neuroblastoma)
cells were found to be more resistant to the treatment of MSN, whether aminated or not. Incubation with
either SBA-15 or MCM-41 over time showed a recovery in cell viability, while exposure to MSN-N
particles did not induce a noticeable cell death until longer incubation with high dosage of 200 µg/mL
was applied. Both aminated and nonaminated silica spheres exhibited instant and constant toxicity on
Jurkat (human T-cell lymphoma) cells. TEM images revealed successful endocytosis of SMS and SMSN, although SMS-N appeared to accumulate more in the nucleus. For SK-N-SH cells, low dosage of
SMS was found to be less toxic, whereas high dosage produced profound cell death.
1. Introduction
The introduction of nanotechnology into biology and medicine
ushers the development of both material and biological sciences
into a new era. Nanomaterials have been widely considered as
promising candidates for drug delivery, gene transfection,
medical imaging, and tumor targeting, mainly due to their highly
ordered structure, unique physical and chemical properties, and
large surface area (1–12). In particular, research breakthroughs
on morphology control and surface functionalization have given
the particles at nanometer scale a wide range of possible
applications in biological systems (13–19). Consequently, the
potential adverse effects of these particles on the environment
or human health have attracted increasing attention from
researchers, as reports on cytotoxicities of carbon nanotubes,
quantum dots, or metal nanoparticles have mushroomed in the
recent years (20–27). The possible cytotoxicities of nanomaterials could result from cellular injuries through a variety of
mechanisms, such as membrane peroxidation, glutathione depletion, mitochondrial dysfunction, and DNA damage, eventually
leading to cell death. Hence, systematic examinations concerning
the biocompatibility of nanomaterials are necessary prior to their
medicinal use.
Mesoporous silica nanoparticles (MSN) are synthesized by
self-assembling the silica source (e.g., tetraethyl orthosilicate)
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with surfactant templates under conditions of various pH
(28–30). The reactions lead to the formation of nanosized silica
spheres or rods with different porous structures, distinguishable
by characteristic mesostructures, pore size and volume, wall
thickness, and surface area per unit mass. The large internal
space of mesopores allows MSN to load biomolecules (such as
hormones and proteins) or drugs and facilitates their delivery
to intracellular destinations. This mini-Trojan Horse trespass
can be further enhanced by grafting MSN with customized
organic groups, either on the external surfaces or inside the
mesoporous channels (6–12). The unique chemical and physical
properties of MSN have been employed by researchers to
fabricate efficient catalysts, sensitive biosensors, and sitedirected drug carriers.
As elite members in the MSN family, MCM-41 and SBA15 are currently examined as the next generation of drug delivery
or neurotransmitter systems (31–33). Both types of MSN
exhibited distinguishable differences in their individual lattice
spacing, pore diameter, wall thickness, surface area, and shape
regularity. Although the advantages of these MSNs for adsorption and release of pharmaceutical molecules have been widely
studied, the cellular responses to treatment of these nanomaterials have been less examined. A few recent studies showed
the rapid endocytosis of MCM-41 in Vitro in various malignant
or normal cell lines (12, 34–37). Further reports on cytotoxicity
of silica nanoparticles suggested that low concentrations of MSN
were more biocompatible than high doses (38, 40). Results from
an in ViVo mouse model treated by either MCM-41 or SBA-15
indicated that MSNs were non- or less-toxic to local tissues
but induced serious systemic toxicity. Furthermore, it was
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proposed that these toxicities could be lessened by decorating
surfaces of the particles with certain functionalized groups (40),
although this was not demonstrated experimentally. We previously studied the effects of MSN (SBA-15 and MCM-41) on
cellular bioenergetics and showed that the mesoporous silicates
impacted mitochondrial functions in a manner dependent on their
physical properties (38). Both particles inhibited oxygen consumption by isolated mitochondria and submitochondrial particles, but only SBA-15 (not MCM-41) impaired cellular
respiration in a dose-dependent manner (38). The submitochondrial particles (SMP), which are mitochondria with the inner
membrane outside, were prepared by proper sonication (41).
MSN particles at low concentrations (50 µg/mL) were found
to have minimal effects on cellular ATP formation, while 200
µg/mL SBA-15 (not MCM-41) significantly diminished intracellular ATP formation. More interestingly, impairments by
SBA-15 of either cell respiration or ATP synthesis changed over
time, followed sometimes by a full recovery (38).
Here, we study the cellular uptake and cytotoxicity of MSNs.
Comparison between MCM-41 and SBA-15 could point out the
morphological effects on the different biological functions of
these nanoparticles. To emphasize the effect of mesoporous
structures on cellular responses, we utilized a silica microsphere
(SMS, ∼300 nm diameter) as a control in these experiments.
Moreover, to examine the influence of functionalized groups,
we also studied the endocytosis and cytotoxicity of organic
grafted MSN and SMS with quaternary amines.

2. Experimental Section
2.1. Chemicals and Reagents. Cetyltrimethylammonium bromide (CTAB), tetraethyl orthosilicate (TEOS), and poly(ethylene
oxide)-block-poly(butylene oxide)-block-poly(ethylene oxide) (P123,
EO20PO70EO20) were obtained from Sigma-Aldrich. N-Trimethoxysilylpropyl-N,N,N-trimethyl ammonium chloride (C9H24ClNO3Si,
abbreviated as TOSPTA, m.w. 257.83, 50% in methanol, and CAS#
35141-36-7) was purchased from Gelest, Inc. (Morrisville, PA).
2.2. Synthesis of SBA-15, MCM-41, and SMS Nanoparticles. SBA-15 was synthesized as reported by using P123 in
acidic solution as a template (28, 29). Typically, a solution of
EO20PO70EO20/2 M HCl/tetraethoxysilane (TEOS)/H2O ) 2:60:
4.25:15 (mass ratio) was stirred at 40 °C for 20 h and then aged at
80 °C for another 24 h. The solution was then filtered, and the solid
was washed with a large amount of water resulting in as-synthesized
SBA-15. This was followed by calcination of the as-synthesized sample
to remove the template at 600 °C for 6 h with a heating ramp of 1
°C/min, followed by a cooling ramp of 2 °C/min.
The synthesis of MCM-41 was done by following a reported
procedure with minor modification (30, 31). CTAB (4.0 g (1.1
mmol)) was dissolved in 960 mL of Millipore water and then mixed
with 14 mL of 2.0 M NaOH solution. The solution was moderately
stirred at 80 °C for 30 min, which was then followed by the addition
of 22.6 mL (101.2 mmol) of TEOS. After stirring for another 2 h
at 80 °C, the solution was filtered, and the precipitate was rinsed
with Millipore water (4 × 80 mL), followed by rinsing with ethanol
(4 × 80 mL) and drying in the oven at 80 °C. To remove the
template, 6 g of the as-synthesized MCM-41 was stirred in a mixture
of 3 mL (12.1 N) of hydrochloric acid and 600 mL of anhydrous
ethanol at 50 °C for 5 h. The resulting material was filtered and
washed with copious amounts of Millipore water and ethanol. The
extracted MCM-41 was dried in the oven at 80 °C overnight before
further modification of its surface.
Silica microspheres were synthesized by following a well-known
Stöber method (42–44). TEOS (5.84 g) was added to 10 mL of 5
M ammonia solution (30 wt %) in a mixture of 50 mL of ethanol
and 3.6 g of Millipore water under stirring to allow the hydrolysis
of TEOS. After stirring for 12 h, a colloidal solution of silica spheres
was obtained. The solution was centrifuged at 6500 rpm for 5 min,
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and the supernatant was decanted. The precipitate was then
redispersed in a mixture of 20 mL of Millipore water and 20 mL
of ethanol. The centrifugation and redispersing process was repeated
several times to remove any unreacted chemicals. The resulting
silica microspheres were dried before further modification.
2.3. Surface Functionalization of MSN and SMS with
Quaternary Ammonium Groups. To functionalize all of the silica
nanoparticles, 300 mg of the particles (SBA-15 after calcinations,
MCM-41 after extraction, and SMS after synthesis) was dispersed
in 150 mL of 2-propanol. Then, 1.15 mol (i.e., 615 µL) of
N-trimethoxysilylpropyl-N,N,N-trimethyl ammonium chloride (TOSPTA, 50% in methanol) was added to the reaction mixture. The
reaction was kept refluxing at 80 °C for 6 h, after which the solution
was filtered, and the precipitate was rinsed with ethanol five times
(80 mL each time). The final product was dried in the oven
(overnight) before use. For simplicity, the amine-grafted samples
were denoted as SBA-N, MCM-N, and SMS-N, respectively.
2.4. Characterizations of Silica Nanoparticles. The nitrogen
physisorption measurement was carried out for all of the nanomaterials (with amine groups or without) at 77 K, using BET
Micromertitics Tristar 3000 after outgassing the samples at 433 K
for 2 h. This characterization also yielded total BET surface area,
pore volume, and pore size distributions for each nanoparticle.
Elemental analysis was later employed on amine-functionalized
nanoparticles to measure the C, H, and N contents in all of the
particles by weight.
2.5. Cell Cultures. The human T-cell lymphoma (Jurkat) and
human neuroblastoma cells (SK-N-H) were obtained from the
American Type Culture Collection (Manassas, VA). Jurkat cells
were grown in standard RPMI 1640 media supplemented with 10%
(v/v) fetal bovine serum with 100 µg/mL streptomycin, 100 IU
penicillin, and 2.0 mM L-glutamine (Mediatech Inc., Herndon, VA).
SK-N-H cells were cultured in EMEM (10-010) supplemented with
10% fetal bovine serum, 100 µg/mL streptomycin, 100 IU/mL
penicillin, and 2.0 mM L-glutamine. Cell studies were carried out
under standard conditions in a humidified, 37 °C, 5% CO2
atmosphere. The neuroblastoma cells were removed from the flasks
using a cell stripper (Mediatech, Herndon, VA) and counted using
trypan blue (Mediatech, Herndon, VA). They were seeded in 75
cm2 vented flasks, allowed to adhere overnight to the surface of
the flask prior to the use for the incubations with nanoparticles.
The average viability of each cell line was determined prior to
seeding by light microscopy using a hemacytometer under standard
trypan blue conditions.
2.6. Cytotoxicity Assay in Vitro. Cytotoxicities of MSN or SMS
were evaluated on Jurkat and SK-N-SH cells by using the standard
cell counting kit (CCK-8, Dojindo Molecular Technologies, Inc.,
Rockville, MD). A 96-well plate was utilized for the cell placement.
Then, 100 µL/well cell-free media or cell suspension was distributed
into a row of at least 6 wells for statistical purposes (n ) 6-12).
For SK-N-SH cells, 6000 cells per well were plated 24 h before
the addition of nanoparticles. For Jurkat cells, 8000 cells/well were
plated and immediately treated with nanoparticles. MSN, SMS, and
the amine-grafted nanoparticles of three various concentrations (50,
100, and 200 µg/mL, respectively) were added. Plates were then
incubated at 37 °C with 5% CO2 for 3 days. Each day, the plates
were taken, followed by the addition of 10 µL of WST-8 agent
(i.e., 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt), which can be bioreduced by cellular dehydrogenases to a water-soluble orange
formazan product. The amount of this formazan product is
proportional to the number of living cells. After another 3 h of
incubation, the absorbance (Abs) was measured at 450 nm using a
microplate reader. The result of subtracting the intensity of the cellfree medium with the addition of various nanoparticles from that
of nanoparticle-treated cells gave an absorbance proportional to the
number of living cells. The mitochondrial activity was hence
measured quantitatively. The ratio between absorbance from cells
treated with nanoparticles and that from untreated cells represents
cell viabilities under various treatments (the viability of untreated
cells was presumably 100%). Namely, cell viability was determined
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as {(Abstreated - Absmedia/Absuntreated - Absmedia) ( standard deviation}
% (n ) 6-12).

2.7. Cell Images by TEM and Bright Field Microscopy.
Jurkat cells (0.5 million cells/mL) were incubated with 200 µg/mL
nanoparticles (SBA-5, MCM-41, and silica microsphere, grafted
with or without quaternary amines) for 1 h and kept gently stirring.
Then, 1.5 mL cell suspensions were collected and centrifuged. The
cell pellets were soaked with 2.0% glutaraldehyde in 0.1 M
cacodylate buffer (BOC, pH 7.4) for 2 h at 4 °C. The cell pellets
were rinsed 3 times within the same BOC buffer, each time by 10
min of centrifugation. After careful washing, the cell pellets were
mixed in BOC with 1% osmium tetroxide (OsO4) for 1 h at 4 °C,
followed by washing again 3 times with BOC. The resulting cell
pellets were mixed with 2% agarose, forming jello-like cell samples.
The cell samples were cut into pieces and subsequently dehydrated
in 25% (10 min), 50% (10 min), 75% (overnight), 95% (10 min),
100% (10 min), and another 100% (10 min) ethanol. The polymerization process was completed by embedding cell samples in resin
plates, infiltrated with a series of mixtures of resin and polyepoxide
at ratios of 2:1 (4 h), 1:1 (4 h), and 1:2 (4 h), ending with 100%
polyepoxide (4 h). The samples were then microtomed for TEM.
Bright field microscopy (Nikon EPIPHOTO 300, Japan) with
built-in photographic equipment (Nikon FX-series) was utilized for
observations of SK-N-SH cells under treatment of various nanoparticles. Cells were first replaced in a 96-well plate, and 24 h later,
various concentrations of different nanoparticles were added. Then,
3 h after the addition of WST-8 reagent, the cells were taken for
cell viability tests in a plate reader as well as for further
morphological observations under bright filed microscopy.

3. Results and Discussion
3.1. Synthesis and Characterization of Nanoparticles. The
syntheses of the MCM-41 and SBA-15 MSN were described
in the Experimental Section. In the case of SBA-15, the synthesis
was followed by calcination to remove the template; in the case
of MCM-41, the as-synthesized sample was washed thoroughly
in a mixture of HCl and ethanol. Both extraction processes result
in the formation of orderly mesostructured nanoparticles. The
transmission electron microscopy (TEM) images (Figure 1A and
B) showed that the extracted MCM-41 nanomaterials were rather
regular spherical particles of 300-350 nm in size, while the
calcined SBA-15 materials were irregularly shaped particles of
various sizes. These two kinds of MSNs were further characterized by nitrogen physisorption measurements, and both showed
type IV isotherms with steep capillary condensation steps
(Figures S1 and S2, Supporting Information), confirming the
presence of mesoporous structures with large surface areas. For
MCM-41, the BET surface area measurement gave a surface
area of 1067 m2/g. Porosity by the Barrett-Joyner-Halenda
(BJH) method exhibited 31.5 Å averaged pore diameter and
1.08 cm2/g cumulative pore volume. These results are summarized in Table 1. The SBA-15 nanomaterials have a measured
surface area of 930 m2/g, an averaged pore width of 59.2 Å,
and a cumulative pore volume of 0.98 cm3/g. Therefore,
compared to SBA-15, MCM-41 owns a slightly bigger surface
area and pore volume. However, the distinguishing difference
of the MCM-41 material from its SBA-15 counterpart dwells
in its much larger pore surface area (2.1-fold) but smaller pore
size (0.5-fold). Spherical silica microspheres (SMS) were also
synthesized by following the conventional Stöber method
(42–44). Adjusting ammonia concentrations produced quite
symmetrical silica spheres with a diameter of ∼300 nm (Figure
1C). The nitrogen physisorption measurement of SMS gave a
BET surface area of 11.3 m2/g and a cumulative pore volume
of 0.04 cm3/g. The latter characteristics reflected a poor porosity
of SMS nanoparticles, corroborating their solid-cored structure.

Figure 1. TEM images of (A) SBA-15, (B) MCM-41, and (C) SMS
nanoparticles.

The surface functionalization of these nanoparticles was
achieved by grafting amine groups, using N-trimethoxysilylpropyl-N,N,N-trimethylammonium chloride (C9H24ClNO3Si, i.e.,
TOSPTA). As a result, the positively charged quaternary amines
were tethered onto both external and internal surfaces of SBA15 and MCM-41, and the external surface of SMS, to produce
aminated particles (noted as SBA-N, MCM-N, and SMS-N,
respectively). TEM images of all of these nanoparticles confirmed that their structures remained unchanged after amination
(results not shown). Nevertheless, further nitrogen physisorption
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Table 1. Characteristics of Silica Nanoparticlesa
Type of
nanoparticles

BET surface
area (m2/g)

BJH pore
width (Å)

pore volume
(cm2/g)

MCM-41
SBA-15
SMS
MCM-N
SBA-N
SMS-N

1067
930
11
905
376
8

31.5
59.2
N/A
29.1
56.2
N/A

1.08
0.98
0.04
0.63
0.57
0.03

a
BET surface area, average pore width, and pore volume are
measured for ungrafted (MCM-41, SBA-15, and SMS) and grafted
(MCM-N, SBA-N, and SMS-N) nanomaterials.

measurements revealed some changes in particle characters due
to chemical grafting (see Table 1). For MCM-N, the nitrogen
adsorption measurement gave a BET surface area of 905 m2/g
and a BJH pore diameter of 29.1 Å, slightly reduced from that
of ungrafted MCM-41. In addition, the amine-functionalized
MCM had a cumulative pore volume of 0.63 cm3/g and pore
surface area of 867 m2/g (0.6- and 0.8-fold those of MCM-41,
respectively), verifying the existence of the amine functional
groups mostly inside the porous MCM channels. As for SBAN, it showed a measured surface area of 376 m2/g, an averaged
pore width of 56.2 Å, and a cumulative pore volume of 0.57
cm3/g. In contrast to those of SBA-15, the physical properties
of functionalized samples were changed because of the reactions
with quaternary amines. That is, the surface area of SBA-N
became 0.4-fold smaller, and both the pore volume and surface
area of SBA-15 became 0.4- and 0.6-fold smaller, implying that
considerable amine groups were grafted on interior surfaces of
SBA-N. For SMS-N particles, the gas physisorption measurement returned a surface area of 7.5 m2/g (0.7-fold that of
unaminated SMS) and a cumulative pore volume of 0.03 cm3/
g, showing the preservation of the solid structure of silica
spheres with amine groups on the external surface of SMS-N.
All of the amine-functionalized silica nanoparticles were
further characterized by elemental analyses (Table S1, Supporting Information). For MCM-N, the mass ratio among C,
H, and N elements is 11.41:2.78:1.79; if converted to mole ratio,
C:H:N ) 8:22:1. This result was fairly consistent with the
elemental composition of TOSPTA (C9H24ClNO3Si), which
confirms that the presence of C, H, and N elements in MCM-N
is primarily due to the grafting of TOSPTA. Upon the basis of
this fact, we calculated that 0.13 mol (i.e., 33.0 g) TOSPTA
was grafted on every 100 g of MCM-N. For SBA-N nanomaterials, the mass ratio among C, H, and N elements is 9.45:
2.32:1.36, i.e., C:H:N ) 8:24:1 in mole ratio, which was quite
in agreement with the elemental composition of TOSPTA,
supporting the idea that the C, H, and N elements in SBA-N
were principally introduced by TOSPTA amination. Hence,
∼0.10 mol (i.e., 25.0 g) TOSPTA was grafted on every 100 g
of SBA-N nanoparticles. For SMS-N particles, the composition
of N elements was <0.05% by weight, suggesting an ineffective
amination on the external surface of solid spheres. The mass
ratio between C and H elements was 1.00:0.92, i.e., C:H ) 1:11
in mole ratio. Therefore, relying on the component of C element
in the samples, we calculated that <0.01 mol (i.e., 2.5 g)
TOSPTA was grafted on every 100 g of SMS-N.
3.2. Cytotoxicity of Silica Nanoparticles. The quantitative
measurements of the cytotoxicity of the nanomaterials were
performed by following the procedures described in the Experimental Section. Figure 2A and Table 2 demonstrate the cell
viability in the presence of different concentrations of SBA-15
nanoparticles. Apparently, at a low dosage of 50-100 µg/mL,
SBA-15 nanomaterials had a minimal effect on the viability of
Jurkat cells during a short time exposure of 3 h. However, at

Figure 2. Jurkat cell viability due to the treatment of various silica
nanoparticles: (A) SBA-15, (B) MCM-41, and (C) SMS, at different
dosages employed (as indicated). Bars filled with dots, lines, or dashes
represent the cell viability at different incubation times of 3, 27, or 51 h,
respectively. Standard deviations were obtained from n ) 6 measurements.

200 µg/mL, SBA-15 executed an immediate toxicity on Jurkat
cells (∼20% dead). At 27 h, both 50 and 100 µg/mL SBA-15
had an increasing impact on cell viability, as 200 µg/mL SBA15 caused ∼30% cell death. This result suggested that the
cytotoxicity of SBA-15 on Jurkat cells was dose-dependent as
well as time-dependent. At 51 h of incubation, neither 50 nor
100 µg/mL SBA-15 exerted an evident toxicity on Jurkat cells,
albeit the fluctuations in cell viability were quite large, while
the dosage of 200 µg/mL exhibited a profound toxicity.
Moreover, during an incubation for a total of 51 h, the doubling
time was found to be (25.5 ( 1.8) h in untreated cells, (33.0 (
3.1) h in 50 µg/mL SBA-15-treated cells, (30.5 ( 4.8) h in 100
µg/mL SBA-15-treated cells, and (25.2 ( 1.4) h in 200 µg/mL
SBA-15-treated cells. Hence, the inhibitory effect of SBA-15
particles on Jurkat cell proliferation was small.
Figure 2B and Table 2 show the cytotoxicity and cell viability
due to the incubation with 50, 100, or 200 µg/mL MCM-41
nanoparticles. Clearly, at all dosages applied, MCM-41 nanomaterials had no observable effect on Jurkat cell viability during
3 h of incubation. This is consistent with our previous findings
that MCM-41 had no significant inhibition on cell respiration
in the same period of incubation, whereas SBA-15 impaired
cellular respiration in a dose-dependent manner (38). However,
at 27 h, cell viability dropped significantly in the three dosages
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Table 2. Cell Viability in the Presence of Different Concentrations of Silica Nanoparticlesa
SBA-15
MCM-41
SMS

dosage (µg/mL)

3 h incubation

p-value

27 h incubation

p-value

51 h incubation

p-value

50
100
200
50
100
200
50
100
200

114.9 ( 11.2
104.1 ( 10.2
77.5 ( 7.3
92.9 ( 11.2
109.4 ( 9.9
99.5 ( 9.2
91.4 ( 12.1
79.3 ( 7.4
80.9 ( 11.7

0.16
0.62
<0.01
0.02
0.51
0.06
0.11
<0.004
0.03

80.7 ( 4.7
83.4 ( 5.5
67.9 ( 6.2
73.7 ( 6.0
71.5 ( 6.4
72.2 ( 7.4
72.9 ( 5.3
78.7 ( 6.4
77.1 ( 4.2

0.02
0.03
<0.001
<0.001
<0.006
<0.008
<0.003
<0.007
<0.004

85.2 ( 7.5
84.0 ( 14.0
78.5 ( 5.3
81.6 ( 3.7
75.4 ( 3.1
71.7 ( 3.4
81.9 ( 5.2
76.9 ( 4.4
77.4 ( 9.1

0.13
0.32
<0.01
<0.003
<0.002
<0.0004
<0.008
<0.0003
<0.02

a

Eight thousand Jurkat cells/well were plated and immediately treated with nanoparticles. SBA-15, MCM-41, and SMS of three concentrations (50,
100, and 200 µg/mL, respectively) were added. Plates were then incubated at 37 °C with 5% CO2 for 3 days. Each day (i.e., 0, 24, and 48 h), plates
were taken, followed by adding 10 µL of WST-8 agent and incubated for another 3 h. The absorbance was then measured at 450 nm using a microplate
reader. Cell viability under each condition, compared to that of the untreated cells, was summarized.

applied. It was, therefore, concluded that 50-200 µg/mL MCM41 had a remarkable toxicity on Jurkat cells. Furthermore, this
toxicity tended to be independent of particle amount over a long
period of exposure. The cell viability on the next day remained
nearly unchanged or revealed a minute recovery, implying a
limited cytotoxicity of MCM-41. The calculations with respect
to the cell doubling time illustrated that 50 µg/mL MCM-41
prolonged Jurkat cell replication by (2.8 ( 2.8) h (i.e.,
statistically zero), 100 µg/mL by (10.2 ( 2.4) h, and 200 µg/
mL by (8.5 ( 2.5) h. Taken together, there was no recognized
cell death by MCM-41 treatment unless there was a long
exposure (after one-day), although cell growth was eventually
inhibited in a dose-dependent manner.
Jurkat cells incubated with 50, 100, or 200 µg/mL SMS
nanoparticles for different incubation times (Figure 2C and Table
2) displayed various cell viabilities over time. During the first
3 h of incubation, except at a dosage of 50 µg/mL, the solid
SMS nanoparticles were lethal to Jurkat cells. One day later,
SMS at 50-200 µg/mL had an appreciable toxicity on Jurkat
cells. This toxicity appeared acute for high doses of SMS, but
chronic for low doses. Moreover, once the toxicity became
evident, it turned out to be dose-independent. With one more
day of incubation, it exhibited a constant cell death in the
presence of SMS. Cell doubling time was then calculated,
yielding (27.8 ( 2.7) h for 50 µg/mL, (26.1 ( 1.3) h for 100
µg/mL, and (26.4 ( 3.4) h for 200 µg/mL SMS-treated cells.
Essentially, SMS had no inhibitory effect on cell growth.
Being an efficient anticancer drug, cisplatin induced cell death
through caspase-dependent apoptosis (45, 46). In Jurkat cells,
experiments done within the same incubation period under
treatment of 40 µM cisplatin showed a cell viability of (75.1 (
9.5) % in the first day and dropped to zero in the second day.
As for the concerns that the cytotoxicity induced by nanoparticles might come from the physical wrappings or surroundings
of particles on cell surfaces, experiments by laying down
nanoparticles first into plates and later gently adding cell
suspensions were performed. Similar results were obtained,
which became in line with the recent report by Hudson et al.
(40). Considering the possible interference or adsorption of
WST-8 by silica nanoparticles, we realized that in the cell-free
medium, various types of particles (SBA-15, MCM-41, and
SMS) yield different light absorbance, on the basis of the same
mass addition. However, with the same particle present, the
differences in absorbance from different concentrations (50, 100,
or 200 µg/mL) were negligible.
To investigate whether the cytotoxicity of the nanoparticles
was dependent on cell type, similar experiments using adherent
SK-N-SH cells that derived from human neuroblastma were
conducted (Figure 3 and Table 3). At 3 h, SBA-15 nanomaterials
exhibited notable toxicity on SK-N-SH cells in a dose-dependent

Figure 3. SK-N-SH cell viability due to the treatment with various
silica nanoparticles: (A) SBA-15, (B) MCM-41, and (C) SMS, at
different dosages employed (as indicated). Bars filled with dots, lines,
or dashes represent the cell viability at different incubation times of 3,
27, or 51 h, respectively. Standard deviations were obtained from n )
6 measurements.

manner, although they nearly had no effect on cells at a low
dosage of 50 µg/mL. This cytotoxicity appeared similar to that
on Jurkat cells. Twenty-four hours later, neither 50 nor 100 µg/
mL SBA-15 showed an inhibitory effect on cell viability,
whereas the cytotoxicity of 200 µg/mL SBA-15 remained
constant. This result implied that the injury of SBA-15 nanoparticles on SK-N-SH cells was dose-dependent and that cells
could recover from injuries due to a relatively low dosage. At

1874

Chem. Res. Toxicol., Vol. 22, No. 11, 2009

Tao et al.

Table 3. SK-N-SH Cell Viability due to the Treatment with SBA-15, MCM-41, and SMSa
SBA-15
MCM-41
SMS

dosage (µg/mL)

3 h incubation

p-value

27 h incubation

p-value

51 h incubation

p-value

50
100
200
50
100
200
50
100
200

98.0 ( 13.3
87.6 ( 3.4
72.4 ( 4.0
84.5 ( 10.7
72.9 ( 8.3
73.8 ( 6.7
93.8 ( 6.8
96.0 ( 11.6
79.6 ( 4.0

0.99
<0.008
<0.0002
0.02
0.005
<0.001
0.29
0.83
<0.002

109.8 ( 4.3
100.9 ( 6.4
78.8 ( 4.0
90.1 ( 14.7
82.6 ( 9.6
54.5 ( 9.5
94.2 ( 6.6
86.3 ( 6.2
70.0 ( 2.8

<0.003
0.46
<0.003
0.46
0.07
0.003
0.66
0.07
<0.0004

98.2 ( 3.3
110.3 ( 4.9
91.1 ( 4.5
99.4 ( 4.9
97.7 ( 4.1
74.2 ( 5.8
98.8 ( 3.6
88.7 ( 3.5
67.7 ( 3.5

0.65
0.003
0.05
0.21
0.68
0.004
0.005
0.02
<0.0004

a

Six thousand SK-N-SH cells per well were plated 24 h before the addition of nanoparticles. Time zero corresponds to the addition of three
concentrations (50, 100, and 200 µg/mL, respectively) of SBA-15, MCM-41, and SMS. At each day (i.e., 0, 24, and 48 h), plates were taken, followed
by the addition of 10 µL of WST-8 agent, and incubated for another 3 h. The absorbance was then measured at 450 nm using a microplate reader. Cell
viability under each condition, compared to that of the untreated cells, was summarized.

51 h of incubation, as 50 and 100 µg/mL SBA-15 continued a
minimal cytotoxicity on SK-N-SH cells, the cell viability under
treatment of 200 µg/mL SBA-15 denoted a recovery over time.
In addition, 50-200 µg/mL SBA-15 did not substantially
lengthen the doubling time of SK-N-SH cells (results not
shown). Compared to the toxicity on Jurkat cells, SBA-15 had
a similar toxic effect on SK-N-SH cells, which was dependent
on the concentrations of nanoparticles. However, differing from
Jurkat cells, the SK-N-SH cells showed more resistance to the
treatment of SBA-15, as the cytotoxicity caused by high dosage
to the latter decreased over time.
MCM-41 nanomaterials also showed toxicity to SK-N-SH cells
during the short exposure (3 h) in a manner similar to that of SBA15 (Figure 3B and Table 3). However, this toxicity was different
from that on Jurkat cells, where MCM-41 had no observable effect
on cell viability at the same incubation period. At 27 h, the toxicity
induced by 50-100 µg/mL MCM-41 was slightly decreased over
time. However, the toxicity persisted when cells were incubated
with 200 µg/mL MCM-41. Furthermore, the viability at 51 h
suggested a full recovery in 50 and 100 µg/mL MCM-41-treated
cells. A partial recovery was also found in 200 µg/mL MCM-41treated cells, although cell death remained evident. All of these
results implied that there was a changeable and recoverable toxicity
of MCM-41 on SK-N-SH cells. The calculations of cell doubling
time revealed that 50-200 µg/mL MCM-41 did not essentially
prolong SK-N-SH cell duplication (results not shown). Obviously,
compared to the results obtained from the study on Jurkat cells,
MCM-41 had a more acute toxicity on SK-N-SH cells; the cells,
however, eventually become more resistant to death with the
MCM-41 treatment.
Viability of SK-N-SH cells, incubated with 50, 100, or 200 µg/
mL SMS nanoparticles (Figure 3C and Table 3), indicated that
silica nanoparticles with solid cores were not toxic to SK-N-SH
cells unless a high dosage of 200 µg/mL was applied at 3 h
exposure. One day later, at a dosage of 50 µg/mL, SMS remained
harmless to SK-N-SH cell viability, while 100-200 µg/mL SMS
had increasing cytotoxicity. Finally, the experiment at 51 h indicated
that SMS treatment exhibited a constant toxicity on SK-N-SH cells,
which appeared acute for high doses of SMS but chronic for low
doses. SMS had no inhibitory effect on growth SK-N-SH cells
because the cell doubling time under 50-200 µg/mL SMS
treatment showed no statistical difference compared to that of the
cells that were not treated with SMS (results not shown).
Similar experiments, incubating SK-N-SH cells with 40 µM
cisplatin, revealed a viability of (84.0 ( 7.4) % at 3 h. This
value was dropped to (5.1 ( 2.1) % at 27 h and became
completely zero at 51 h. Therefore, cisplatin executed cell death
on neuroblastoma cells similar to that on Jurkat cells. A bright
field microscopy was utilized for observations of SK-N-SH cells
under treatment of 200 µg/mL nanoparticles or 40 µM cisplatin

during a 24-h incubation. The images were then taken and
shown in Figure 4. In cells incubated with various nanoparticles,
SBA-15 (Figure 4B), MCM-41 (Figure 4C), or SMS (Figure
4D), the surfaces of the cells were partially covered or
surrounded by particles. Compared to the untreated cells (Figure
4A), the morphology of the cells was not changed after treatment
with nanoparticles, confirming a limited cytotoxicity that was
not induced by physical wrapping of nanomaterials. Simultaneously, the majority of cells tended to be dying because of
the exposure to cisplatin (Figure 4E), forming groups of
apoptotic bodies.
3.3. Cytotoxicity of Functionalized Silica Nanoparticles.
To further explore the effect of surface functionalization on
induced cytotoxicity, we functionalized silica nanoparticles with
quaternary amine groups (noted as SBA-N, MCM-N, and SMSN) and used them in toxicity studies (Figure 5). Contrary to
the ungrafted SBA-15, SBA-N nanomaterials barely showed
noticeable toxicity to Jurkat cells after a total of 51 h incubation.
In other words, amination largely neutralized the toxicity of
SBA-15 nanoparticles on Jurkat cells. The cell doubling time
was also found to be (24.4 ( 1.5) h in untreated cells and (24.7
( 1.4) h in 50 µg/mL, (24.5 ( 1.5) h in 100 µg/mL, and (22.3
( 1.0) h in 200 µg/mL SBA-N treated cells. Hence, the effect
of amine-functionalized SBA nanoparticles on cell growth was
negligible.
The toxicity of MCM-N on Jurkat cells (Figure 5B and Table
4) with a concentration of 50-200 µg/mL showed little or no
cytotoxicity after a total of 27 h incubation. Within statistical
errors, the cell viability on the next day (i.e., 51 h) kept
unchanged, confirming a perfect biocompatibility of MCM-N
particles without apparent cytotoxicity. The calculations with
respect to the cell doubling time revealed that there was no
inhibition of cell growth under 50-200 µg/mL MCM-N
incubation (results not shown). Thus, amination counteracted
the cytotoxicity of MCM-41 in the same manner as it did to
SBA-15.
In the presence of various concentrations of SMS-N (Figure
5C and Table 4), the viability of Jurkat cells decreased
significantly after a short incubation (3 h), independent of the
doses applied. This instant cell damage lasted for another 48 h.
Therefore, it implied that once treated, SMS-N induced a rapid
as well as constant toxicity to Jurkat cells. Compared to the
effect of SMS on the same cell line, the cytotoxic profiles of
SMS-N nanoparticles were very similar. That is, amination failed
in rescuing Jurkat cells from injury caused by silica spheres.
The calculated cell doubling times for SMS-N were (24.3 (
2.2) h, (22.6 ( 1.2) h, and (22.4 ( 2.0) h for 50, 100, and 200
µg/mL SMS-N treatments, respectively, suggesting that there
was no effect on cell proliferation due to the treatment of SMS-N
particles.
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Figure 4. SK-N-SH cell images under bright field microscope after 24 h of incubation without (A) or with various silica nanoparticles: (B) SBA-15, (C)
MCM-41, and (D) SMS. As a reference, SK-N-SH cells treated with 40 µM cisplatin are also shown in E. Scale bars indicate a size of 600 µm.

The toxicity of MSN-N and SMS-N under different conditions
during various incubation times on SK-N-SH cells was also
measured (Figure 6 and Table 5). SBA-N showed a small
toxicity after 3 h exposure to SK-N-SH cells, similar to that on
Jurkat cells. Cytotoxicity induced by SBA-N particles after 27 h
of incubation increased in a dose-dependent manner. At 51 h,
the treatment of the cells with 50-200 µg/mL SBA-N resulted
in persistent or slightly decreased cell viability. Therefore,
SBA-N had a time-dependent and concentration-dependent
toxicity on SK-N-SH cells. Moreover, 50-200 µg/mL SBA-N
substantially prolonged the doubling time of SK-N-SH cells. It
was (41.7 ( 3.1) h for the untreated cells to replicate, which
was delayed under the treatment of 50 µg/mL SBA-N by (6.9
( 2.7) h, 100 µg/mL SBA-N by (4.3 ( 2.7) h, and 200 µg/mL
SBA-N by (20.8 ( 3.3) h. Thus, compared to its toxicity to
Jurkat cells, SBA-N appeared more toxic to SK-N-SH cells.
More specifically, this enhanced cytotoxicity clearly resulted

from amination since SK-N-SH cells showed more resistance
to the treatment of ungrafted SBA-15.
The cytotoxicity of MCM-N nanoparticles on SK-N-SH cells
is shown in Figure 6B. After 3 h of exposure, MCM-N
nanomaterials were safe to SK-N-SH cells at concentrations of
50-200 µg/mL, which was quite different from MCM-41
samples that had a considerable toxicity on SK-N-SH cells
during the same incubation period. At 27 h, cell death became
noticeable in cells treated by 200 µg/mL MCM-N particles but
not in cells treated by a lower amount of MCM-N. This dosedependent toxic manner remained similar at 51 h, as no toxicity
was observed in 50-100 µg/mL MCM-N-treated cells. However, 200 µg/mL MCM-N led to partial cell death. These results
implied a tolerable toxicity of MCM-N by SK-N-SH cells.
Moreover, the cell doubling time revealed that 50-100 µg/mL
MCM-N had statistically no influence on cell duplication, but
200 µg/mL MCM-N prolonged the doubling time by (10.8 (
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Figure 5. Jurkat cell viability due to the treatment of various aminated
silica nanoparticles: (A) SBA-N, (B) MCM-N, and (C) SMS-N, at
different dosages employed (as indicated). Bars filled with dots, lines,
or dashes represent the cell viability at different incubation times of 3,
27, or 51 h, respectively. Standard deviations were obtained from n )
6 measurements.

4.5) h. Hence, for SK-N-SH cells, a relatively high dosage of
MCM-N inhibited cell growth and induced cell death.
Finally, the cytotoxicity of SMS-N on SK-N-SH cells was
investigated (Figure 6C). At 3 h of incubation, a fluctuation in
cell viability with the addition of nanoparticles reflected a
variable but limited toxicity. SMS-N induced a similar dosage-

independent toxicity on SK-N-SH cells after 24 h as it did on
Jurkat cells. Furthermore, the earlier fluctuation in cytotoxicity
diminished over time, allowing us to determine the material’s
effect on cell death. At a total of 51 h of incubation time, SMS-N
particles had a trivial impact on SK-N-SH cell viability. Further
calculations of the doubling time revealed no difference between
untreated and treated SK-N-SH cells (results not shown). All
of these results demonstrated that functionalization of quaternary
amines on the outer surface of SMS made silica spheres less
toxic to SK-N-SH cells and caused no effect on cell growth.
3.4. Cellular Uptake of Silica Nanoparticles. The cellular
uptake of the silica nanoparticles in cancer cell lines were also
investigated using transmission electron microscopy. If we
assume all of the nanomaterials studied above to be strictly
spherical in shape, a particle with a diameter of 300 nm and a
density of 2.2 g/cm3 (SiO2) has a mass of 3.1 × 10-14 g and a
volume of 1.4 × 10-14 mL. Thus, 200 µg/mL corresponds to
6.5 × 109 particles in 1 mL addition. When we plated 8000
Jurkat cells per well (100 µL), there were ∼8.0 × 104 particles
per cell. Assuming the mean volume of one Jurkat cell as 1.7
× 10-13 L (38), i.e., 1.2 × 104 times that of a single particle
and assuming a spherical shape, we calculated that the surface
area of a Jurkat cell is ∼1.48 × 10-10 m2 or ∼525 times that of
one particle. Hence, the particles added, if all stay in contact
with cells in solution, represent 6.7 times the volume or 153
times the area of the cells. However, it is not clear yet whether
the particles are stuck to the cell surface, internalized by cells,
or both. Thus, our next effort was made to collect evidence in
support of or to discount endocytosis of these silica nanoparticles.
Jurkat cells (0.5 × 106 cells per mL) were incubated with
200 µg/mL nanoparticles (SBA-5, MCM-41, and SMS, grafted
with or without quaternary amines) for 1 h and kept gently
stirring. Cell suspensions (1.5 mL) were then collected, processed, microtomed, and visualized by TEM. As shown in
Figure 7, during 1 h of incubation at 37 °C, Jurkat cells
swallowed SBA-15 (Figure 7A) and MCM-41 (Figure 7B) by
engulfing the particles with their cell membranes. For SBA-15
nanoparticles, the cytoplasm membranes were more likely to
fold inward in order to absorb the material from outside,
suggesting a possible receptor-mediated endocytosis. Normally,
this internalization of extracellular objects would form cytoplasmic vesicles that are coated by cytosolic proteins. Those
particles could travel inside the cytoplasm or even commute
between nuclei and cytosols, as shown in Figure 7A (lower
panel). An internalized SBA-15 particle was seized crossing
the nuclear membrane. However, the mechanism of endocytosis
of MCM-41 particles could be very different. Figure 7B freezes
the moment when MCM-41 nanoparticles were ingested by
Jurkat cells, showing a typical process of phagocytosis. The
cell membranes clearly folded around MCM-41 particles,

Table 4. Toxicity of MSN-N and SMS-N on Jurkat Cellsa
SBA-N
MCM-N
SMS-N

dosage (µg/mL)

3 h incubation

p-value

27 h incubation

p-value

51 h incubation

p-value

50
100
200
50
100
200
50
100
200

102.9 ( 11.0
94.0 ( 10.8
87.5 ( 8.4
103.9 ( 12.2
90.2 ( 8.0
82.3 ( 12.6
79.2 ( 9.5
76.7 ( 8.2
76.1 ( 11.8

0.60
<0.003
0.04
0.62
0.09
0.09
0.003
<0.0001
<0.007

90.7 ( 6.4
86.4 ( 6.4
86.0 ( 7.1
103.7 ( 8.7
89.4 ( 8.7
86.0 ( 6.2
89.7 ( 9.1
77.3 ( 8.8
83.3 ( 9.6

0.05
0.07
0.07
0.35
0.20
0.04
0.11
0.01
0.10

101.4 ( 3.9
93.5 ( 2.7
99.8 ( 5.0
104.8 ( 3.2
94.2 ( 4.6
94.2 ( 2.8
79.8 ( 6.8
85.8 ( 3.8
85.9 ( 2.5

0.26
<0.008
0.93
0.08
0.07
0.07
0.01
0.001
0.0003

a
Eight thousand Jurkat cells/well were plated and immediately treated with nanoparticles. SBA-N, MCM-N, and SMS-N of three concentrations (50,
100, and 200 µg/mL, respectively) were added. Plates were then incubated at 37 °C with 5% CO2 for 3 days. Each day (i.e., 0, 24, and 48 h), plates
were taken, followed by the addition of 10 µL of WST-8 agent, and incubated for another 3 h. The absorbance was then measured at 450 nm using a
microplate reader. Cell viability under each condition, compared to that of the untreated cells, was summarized.
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Figure 6. SK-N-SH cell viability due to the treatment of various aminated silica nanoparticles: (A) SBA-N, (B) MCM-N, and (C) SMS-N, at
different dosages employed (as indicated). Bars filled with dots, lines, or dashes represent the cell viability at different incubation times of 3, 27,
or 51 h, respectively. Standard deviations were obtained from n ) 6 measurements.

Table 5. Toxicity of MSN-N and SMS-N under Different Conditions during Various Incubation Times on SK-N-SH Cellsa
SBA-N
MCM-N
SMS-N

dosage (µg/mL)

3 h incubation

p-value

27 h incubation

p-value

51 h incubation

p-value

50
100
200
50
100
200
50
100
200

93.3 ( 4.9
93.3 ( 5.7
92.0 ( 5.4
95.7 ( 3.9
98.3 ( 4.0
98.7 ( 6.7
90.9 ( 5.0
88.8 ( 4.4
95.9 ( 5.7

0.05
0.04
0.02
0.12
0.27
0.59
0.04
0.002
0.18

92.0 ( 4.1
87.7 ( 4.5
73.3 ( 5.4
103.2 ( 4.8
99.1 ( 5.7
88.1 ( 2.9
92.1 ( 6.9
89.0 ( 2.4
90.4 ( 5.5

0.04
0.006
0.001
0.09
0.81
<0.001
0.18
0.001
0.05

83.3 ( 5.8
86.6 ( 5.9
70.6 ( 3.6
95.1 ( 5.0
99.2 ( 7.2
83.8 ( 8.0
93.9 ( 9.9
91.9 ( 6.9
90.8 ( 5.5

0.04
0.04
0.002
0.22
0.88
0.07
0.43
0.04
0.04

a
Six thousand SK-N-SH cells per well were plated 24 h before the addition of nanoparticles. Time zero corresponds to the addition of three
concentrations (50, 100, and 200 µg/mL, respectively) of SBA-N, MCM-N and SMS-N. At each day (i.e., 0, 24, and 48 h), plates were taken, followed
by the addition of 10 µL of WST-8 agent, and incubated for another 3 h incubation. The absorbance was then measured at 450 nm using a microplate
reader. Cell viability under each condition, compared to that of the untreated cells, was summarized.
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Figure 7. TEM images that visualized the uptake of silica nanoparticles by Jurkat cells. (A) Endocytosis of SBA-15. The cytoplasm membranes
are inclined to fold with an intension to absorb the material from outside. In addition, an internalized SBA-15 nanoparticle was observed penetrating
the nuclear membrane. (B) Endocytosis of MCM-41. Particles are ingested by cells as cell membranes hug around MCM-41 nanoparticles, forming
a pseudopodium. (C) Endocytosis of SBA-N (upper panel) or MCM-N (lower panel). No efficient endocytosis can be observed, as particles stay
outside of cells in the medium. (D) Endocytosis of SMS (upper panel) or SMS-N (lower panel). Internalized solid nanoparticles are indicated by
arrows.

forming a pseudopodium; this was a natural defense of the cell
against unwanted objects, but unfortunately, it failed here. The
hexagonal packing of MCM-41 nanoparticles can be easily
observed inside the cells. However, there was much less efficient
endocytosis observed in cells treated with 200 µg/mL either
SBA-N (upper panel, Figure 7C) or MCM-N (lower panel,
Figure 7C). The positively charged groups on the mesoporous
nanoparticles, produced by grafting of the quaternary amines,
were inclined to bind the negatively charged cell membrane
instead of bringing the materials into the cytoplasm. This actual
failure in endocytosis protected the cells from serious injury,
although the physical damage of the lipid membrane might still
occur.
The endocytotic processes for SMS (upper panel) and SMS-N
(lower panel) are shown in Figure 7D. Basically, the internalization of solid spherical particles was as efficient as that of
mesoporous particles, seeing that ingested silica spheres were
dissipated inside the cells. Close observations along the cell
membrane suggested that the solid-cored spheres diffused across
the cellular boundary, causing severe impairment to the intracellular organelles and therefore promoting cell death. Compared
to that of SMS, the intracellular distribution of SMS-N suggested
that these aminated silica spheres were more likely to accumulate

inside the nucleus, which became in line with the positive charge
and concrete nature of SMS-N particles. Given the fact that a
small amount of SMS-N (50 µg/mL) could immediately execute
more serious cytotoxicity than SMS did, quaternary amines
tended to facilitate the intracellular transportation of silica
spheres, which previously failed the mesoporous particles in
entering cells. This observed difference in endocytosis between
the aminated mesoporous nanoparticles and silica nanospheres
can also be attributed to the possible difference in the degree
of interaction between the nanomaterials and the cell membranes
via such forces as capillary action between the mesopores or
the materials and the cell membranes, whose strength may
depend on the existence of pores on the material nature and the
pore sizes, if any.

4. Conclusions
Silica nanomaterials, including mesoporous MCM-41 and
SBA-15, and solid-cored spheres (SMS), and their ammonium
functionalized counterparts were synthesized, and their cytotoxicities on adherent and suspended cells were investigated.
In Jurkat cells, SBA-15 exhibited cytotoxicity in a timedependent and concentration-dependent manner, while MCM-
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41 showed cytoxicity in a time-dependent but concentrationindependent manner. No significant cell death was detected
when treating the same cells with aminated SBA-N or MCM-N
samples. That is, positively charged quaternary amines prevented
cellular injury from mesoporous nanoparticles. The endocytosis
study confirmed this effect, where the effective internalization
of MSN but not MSN-N was observed. SK-N-SH cells appeared
more resistant to the treatment of MSN, unaminated or aminated.
Incubation with either SBA-15 or MCM-41 over time showed
a recovery in cell viability, while exposure to MSN-N particles
only induced a noticeable cell death at longer incubation with
a high dosage of 200 µg/mL. MSN-N (but not MSN) particles
inhibited SK-N-SH (but not Jurkat) cell doubling time in a dosedependent manner. Whether aminated or not, silica spheres had
an instant and constant toxicicty on Jurkat cells. TEM images
revealed an effective endocytosis of SMS and SMS-N, although
SMS-N appeared to be more likely to enter the nucleus. For
solid silica spheres, although the positive charge due to
amination still made cellular uptake less efficient, the rigid nature
of these particles dismantled cells in a different manner
compared to that of their MSN counterparts. Thus, it can be
concluded that the cytotoxicity of silica nanoparticles is particledependent as well as cell-type dependent. Moreover, this
dependency further varied with incubation time and particle
dosage. This was primarily associated with the endocytotic
efficiency of nanoparticles, which was found to depend largely
on their chemical property, such as the grafting of organic
groups. An excellent work has been recently reported on the
cytotoxicity and biocompatibility of MCM-41, SBA-15, and
mesocellular foam (MCF) on in Vitro mammalian cells as well
as in ViVo mouse models (40). The results indicated that
mesoporous silicates showed a significant degree of toxicity at
high concentrations. Although it was previously proposed that
the toxicity of the materials might be mitigated by modification
of the materials (40) and while our work was consistent with
some of these results, our study here was the first ever to
illustrate the effect of the functionalization of mesoporous
materials on their cytotoxicity both in dose- and cell typedependent manners on adherent and suspended cells.
Acknowledgment. T.A. thanks the US National Science
Foundation (NSF), contract Nos. CHE-0645348 and NSF-DMR
0804846, for the partial financial support of this work. B.B.T.
and Z.T. are grateful to The Arnold Family for supporting part
of this research by Paige’s Butterfly Run. Z.T. is currently a
Japan Society for Promotion of Science postdoctoral fellow in
Graduate School of Medicine, Kyoto University, Japan.
Supporting Information Available: Experimental details,
N2 BET gas adsorption isotherms. and BJH pore-size distributions of the nanomaterials investigated. This material is available
free of charge via the Internet at http://pubs.acs.org.

References
(1) Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., and Rudzinski,
W. E. (2001) Biodegradable polymeric nanoparticles as drug delivery
devices. J. Controlled Release 70, 1–20.
(2) Blumen, S. R., Cheng, K., Ramos-Nino, M., Taatjes, D., Weiss, D.,
Landry, C. C., and Mossman, B. T. (2007) Unique uptake of acidprepared mesoporous spheres by lung epithelial and mesothelioma
cells. Am. J. Respir. Cell Mol. Biol. 36, 333–342.
(3) Solberg, S. M., and Landry, C. C. (2006) Adsorption of DNA into
mesoporous silica. J. Phys. Chem. B 110, 15261–15268.
(4) Brigger, I., Dubernet, C., and Couvreur, P. (2002) Nanoparticles in
cancer therapy and diagnosis. AdV. Drug DeliVery ReV. 54, 631–651.
(5) Rhaese, S., von Briesen, H., Rübsamen-Waigmann, H., Kreuter, J.,
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